Updates are available Correction dated 2024-04-20

Article History

Received: 4 October 2023

Revised: 23 January 2024

Accepted: 26 January 2024

First Online: 2 March 2024

Change Date: 20 April 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1038/s41391-024-00835-x

Competing interests

: NDS: Consulting fees: AbbVie, Alessa Therapeutics, Amgen, Arquer, Asieris, Astellas, Astra Zeneca, Bayer, BMS, Boston Scientific, Clarity, Dendreon, Exact Images, Ferring, FIZE Medical, GConcology, GenesisCare, Genetech, Foundation Medicine, ImmunityBio, Incyte, Invitae, Janssen, Lantheus, Lilly, MDX, Merck, Minomic, Myovant, Myriad, NGM, Nonagen, Novartis, NYMOX, Pacific Edge, Photocure, Pfizer, PlatformQ, Profound, Promaxo, Propella, Protara, Sanofi, Speciality Networks, Telix, Tolmar, Urogen, Vaxiion, Vessi; Payment for expert testimony: Ferring; Other financial or non-financial interests: Alessa, Photocure Board. ESA: Support for present the manuscript: Merck; Grants or contracts: Astellas, AstraZeneca, Bayer, Bristol Myers-Squibb, Celgene, Constellation Pharma, MacroGenics, Merck, Orion, Sanofi; Consulting fees: Aikido Pharma, Corcept Therapeutics, EcoR1, Foundation Medicine, Hookipa Pharma, Invitae, KeyQuest Health, Menarini Silicon Biosystems, z-Alpha; Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: UroWebinar; Support for attending meetings and/or travel: MJH Events, Research to Practice, Sanofi; Patents planned, issued or pending: Qiagen; Participation on a Data Safety Monitoring Board or Advisory Board: Aadi Bioscience/CM Propel, Amgen; Board or Advisory Board: AstraZeneca, Bayer, Blue Earth Diagnostics, Ismar, Janssen, Merck, Sanofi. AHB: Support for present manuscript: Bayer; Grants or contracts: Astellas; Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Merck, Pfizer, Janssen, Myovant, Astra Zeneca, Bayer, Astellas, Novartis; Support for attending meetings and/or travel: Pfizer, Bayer. RRM: Consulting fees: AstraZeneca, Aveo, Bayer, Bristol-Myers Squibb, Calithera, Caris, Dendreon, Eisai, Exelixis, Johnson & Johnson, Lilly, Merck, Myovant, Novartis, Pfizer, Sanofi, SeaGen, Sorrento Therapeutics, Telix, Tempus; Institutional research support: AstraZeneca, Bayer, Tempus, Oncternal, BMS, Exelixis. KLS: Grants or contracts: Dendreon Pharmaceuticals, Alliance Foundation Trials, Pfizer-B8011006, TulsaPRO – Perigon, Landmark Services, Janssen-pending, Merck Master Engagement, Medical Director, Surgery Center, Phase IB Trial of Relugolix and Enzalutamide as Neoadjuv; Consulting fees: Merck & Company Advisory-expired; Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Bayer Speaker Bureau 2022, Carden Jennings Publishing, Elzevier, Ebix Oakstone, National Comprehensive Cancer Network, Society of Urologic Nurses & Associates, ARK Prostate Cancer Symposium; Support for attending meetings and/or travel: Tulsa Pro Perigon – Onsite Case Observation; American Urological Association; National Comprehensive Cancer Network; Participation on a Data Safety Monitoring Board or Advisory Board: Merck; Leadership or fiduciary role in other board, society, committee or advocacy group: Society of Urologic Oncology Trials Consortium – Board of Directors, Prostate Organ Site Comm; Johns Hopkins Medicine/Oakstone Publishing Practical Reviews in Urology; Society of Urologic Oncology-Clinical Trials Consortium Board Of Directors; Society of Urologic Oncology Young Urologic Oncologist. AA: Nothing to disclose. MSC: Grants or contracts: MDXHealth, Clinical Trial Agreement; Royalties or licenses: Springer Nature Group; Consulting fees: Pfizer, Nonagen Bioscience Corp., Propella, Consulting JW, Myovant Sciences, Inc., TesoRx Pharma, LLC, Merck & Co., Inc.; Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Remedica Medical Education & Publishing, MJH LifeSciences Prostate Cancer Roundtable, ASCO Symposium, Clinical Education Alliance, BioPharm Communications, Abstract Reviewer, LynxDX; Payment for expert testimony: Walters, Stanley, Natrajan; Rhodes & Hieryonymus; Williams, Hall, Latherow; Moscarino & Treu; Support for attending meetings and/or travel: American Urological Association (AUA), Society of Urologic Oncology, South Central Section of the AUA, UCSF Grand Rounds, Desai Sethi Urology Institute, American Board of Urology, Onclive (USPROST8CON), American Society of Clinical Oncologists (ASCO), Astellas, Vanderbilt University, Thomas Jefferson University, VP, Southeastern Section of the AUA, University of Wisconsin School of Medicine, VP; Participation on a Data Safety Monitoring Board or Advisory Board: Lantheus Advisory Board, Janssen Pharmaceuticals, Inc. Advisory Board, Pacific Edge Diagnostics USA Ltd., Advisory Board, Janssen Biotech, Academic Urology Advisory Board, Signatera GU Cancers Advisory Board, Bayer Prostate Cancer Advisory Council, Prokarium Ltd Bladder Cancer Advisory Board, Janssen Scientific Affairs, LLC Advisory Board, Bayer, Fallon Medica Advisory Board; Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: American Urological Association (AUA), South Central Section of the AUA, Society of Urological Oncology, Urology Times, American Board of Urology. MDK: Nothing to disclose. CHM: Support for present the manuscript: NCI - P30 CA006973; Grants or contracts: V Foundation; Winn Career Development Award; Prostate Cancer Foundation; Royalties or licenses: McGraw Hill; Consulting fees: Astellas Pharmaceuticals, Obseva, Bayer; Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Mashup MD; Participation on a Data Safety Monitoring Board or Advisory Board: Dendreon. AER: Grants or contracts: Site PI clinical trials with Bayer; Consulting fees: Astellas/Pfizer, Bayer, Blue Earth, Janssen, Lantheus; Payment or honoraria for lectures, presentations, speakers bureaus: Astellas/Pfizer, Blue Earth, Janssen, Lantheus.